BATS BZX Real-Time Price
As of 10:39am ET
| -0.10 / -2.41%|
The 1 analysts offering 12-month price forecasts for Novelion Therapeutics Inc have a median target of 7.00, with a high estimate of 7.00 and a low estimate of 7.00. The median estimate represents a +72.84% increase from the last price of 4.05.
The current consensus among 1 polled investment analysts is to Hold stock in Novelion Therapeutics Inc. This rating has held steady since May, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.